Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
1.
Sci Rep ; 11(1): 16146, 2021 08 09.
Article in English | MEDLINE | ID: mdl-34373544

ABSTRACT

Psoriasis is a chronic inflammatory skin disease that involves various systemic organs and tissues and is characterized by scaly erythematous skin. Among the different types of psoriasis, psoriatic arthritis (PsA) is frequently reported, and occasionally develops into severe arthritis leading to joint dysfunction. There are various tools, especially questionnaires, to identify the presence of PsA in European and American populations; however, little is known about the utility of these tools in the Asian population. In this study, we investigated the utility of a representative tool, the psoriasis epidemiology screening tool (PEST) questionnaire, to identify PsA among Japanese patients with psoriasis. A total of 143 patients with psoriasis were enrolled in this study. Among them, 29 patients were diagnosed with PsA. The frequency of PsA was significantly increased in patients with PEST scores > 3, with a sensitivity of 93.1% and a specificity of 78.9%. Among the questions in the PEST questionnaire, "Have you ever had a swollen joint?" showed the highest frequency to answer "Yes" among patients with PsA. Univariate and multivariate analyses revealed that high PEST scores (> 3) was an independent variable in PsA patients. Taken together, our study suggests that the PEST questionnaire is a useful tool to identify PsA among Japanese patients with psoriasis.


Subject(s)
Arthritis, Psoriatic/epidemiology , Psoriasis/epidemiology , Arthritis, Psoriatic/diagnosis , Asian People , Female , Humans , Japan/epidemiology , Logistic Models , Male , Mass Screening , Middle Aged , Multivariate Analysis , Surveys and Questionnaires
2.
Int J Mol Sci ; 22(11)2021 May 28.
Article in English | MEDLINE | ID: mdl-34071562

ABSTRACT

The skin is the outermost layer of the body and is exposed to many environmental stimuli, which cause various inflammatory immune responses in the skin. Among them, fungi are common microorganisms that colonize the skin and cause cutaneous fungal diseases such as candidiasis and dermatophytosis. The skin exerts inflammatory responses to eliminate these fungi through the cooperation of skin-component immune cells. IL-17 producing cells are representative immune cells that play a vital role in anti-fungal action in the skin by producing antimicrobial peptides and facilitating neutrophil infiltration. However, the actual impact of IL-17-producing cells in cutaneous fungal infections remains unclear. In this review, we focused on the role of IL-17-producing cells in a series of cutaneous fungal infections, the characteristics of skin infectious fungi, and the recognition of cell components that drive cutaneous immune cells.


Subject(s)
Candidiasis/immunology , Fungi/immunology , Interleukin-17/immunology , Skin/immunology , Th17 Cells/immunology , Tinea/immunology , Animals , Candidiasis/microbiology , Fungi/physiology , Humans , Interleukin-17/metabolism , Neutrophil Infiltration/immunology , Pore Forming Cytotoxic Proteins/immunology , Pore Forming Cytotoxic Proteins/metabolism , Skin/microbiology , Th17 Cells/metabolism , Tinea/microbiology
3.
Sci Rep ; 11(1): 5493, 2021 03 09.
Article in English | MEDLINE | ID: mdl-33750880

ABSTRACT

Telaprevir used as a protease inhibitor against hepatitis C virus is frequently associated with cutaneous adverse reactions. To explore a histological biomarker of cutaneous adverse events induced by telaprevir, we systematically searched for genes that were dysregulated by telaprevir in normal human epidermal keratinocytes (NHEKs). Microarray analysis and real-time polymerase chain reaction (PCR) revealed the significant increase in the expression of S100 calcium-binding protein A2 (S100A2) gene following treatment of NHEKs with telaprevir. Immunohistochemical analysis demonstrated that the expression of S100A2 was dominant in the spinous layer of the epidermis in patients with telaprevir-mediated severe-type drug eruptions and limited to the basal layer of the epidermis in healthy subjects. Furthermore, S100A2 expression increased after treatment with trichloroethylene and other medications, and the degree of S100A2 expression correlated with the severity of cutaneous adverse events. S100A2 expression also significantly increased in the skin of patients with atopic dermatitis and psoriasis. Taken together, S100A2 is highly expressed in the epidermis under inflammatory conditions and drug eruptions and may serve as a marker for keratinocyte damage in response to any inflammatory or toxic condition.


Subject(s)
Chemotactic Factors/biosynthesis , Drug Eruptions/metabolism , Gene Expression Regulation/drug effects , Keratinocytes/metabolism , Oligopeptides/pharmacology , S100 Proteins/biosynthesis , Aged , Drug Eruptions/pathology , Female , Hepacivirus/metabolism , Hepatitis C/drug therapy , Hepatitis C/metabolism , Hepatitis C/pathology , Humans , Keratinocytes/pathology , Male , Middle Aged
4.
Gan To Kagaku Ryoho ; 47(7): 1121-1123, 2020 Jul.
Article in Japanese | MEDLINE | ID: mdl-32668866

ABSTRACT

A 60-year-old Khmer woman visited a hospital established by a Japanese non-profit organization in the Kingdom of Cambodia with complaints of swelling in the left abdomen and appetite loss for 2 months. Abdominal computed tomography scan showed a mass measuring 14.6×13.4×19.3 cm with internal necrosis in the left abdomen. On laparotomy, a large tumor involving the jejunum had adhered to the transverse and descending colons. The tumor, measuring 25×20×10 cm and weighing 2,994 g, was excised along with 65 cm of the jejunum. Histopathological examination revealed a gastrointestinal stromal tumor(GIST). Postoperative course was uneventful. Thanks to the cooperation with the Japanese and the Cambodian people, the surgery was successful in spite of a shortage of medical personnel and medical resources in Cambodia.


Subject(s)
Gastrointestinal Stromal Tumors , Jejunal Neoplasms , Cambodia , Female , Humans , Jejunum , Laparotomy , Middle Aged , Tomography, X-Ray Computed
5.
Front Med (Lausanne) ; 7: 609515, 2020.
Article in English | MEDLINE | ID: mdl-33392230

ABSTRACT

Atypical lipomatous tumor (ALT) has been defined as a well-differentiated liposarcoma exhibiting a higher frequency of a local recurrence after surgical resection. ALT is mainly classified into deep type and superficial type. Compared with deep type ALT, superficial type ALT is rarely observed. One of the most important issues is that little has been known about superficial type ALT and it is not easy to predict the presence of superficial type ALT before surgical resection. To clarify the clinical manifestations of superficial type ALT, we examined 15 cases with superficial type ALT and 118 cases with benign lipoma, and analyzed their differences in clinical characteristics and the findings of MRI test. In clinical characteristics, the tumor size of superficial type ALT was significantly greater than that of benign lipoma, and superficial type ALT showed a significantly higher frequency of the tumor size of more than 4 cm. Superficial type ALT exhibited poor tumor mobility and hardness with elastic soft. In addition, a significantly higher frequency of tumor location of superficial type ALT was observed in extremities. Among tumor sites at the trunk, buttocks, and shoulder were high frequent location in superficial type ALT. In an MRI examination, superficial type ALT exhibited a significantly higher frequency of the septal structures compared with benign lipoma. The combinations of clinical characteristics, including physical examinations, MRI, and histological examinations, are helpful for the diagnosis of superficial type ALT.

8.
J Dermatol ; 45(12): 1452-1455, 2018 Dec.
Article in English | MEDLINE | ID: mdl-30204257

ABSTRACT

Melanoma is a malignant tumor of the melanocytes with an unfavorable clinical behavior. Nivolumab, a representative anti-programmed death 1 (PD-1) antibody, has recently been used for the treatment of metastatic malignant melanoma. However, there have been few appropriate biomarkers predicting the effect of nivolumab before the administration. Furthermore, the detailed characteristics of peripheral blood mononuclear cell (PBMC) profiles during nivolumab treatment remains unclear. In this study, we investigated fluctuations of PBMC profile during nivolumab treatment. PBMC analysis showed T-helper (Th)2-dominant conditions after a first course of nivolumab treatment. In a favorable case treated with nivolumab, a Th1/T-cytotoxic 1 shift was observed after nivolumab was administrated. These results suggest that flow cytometric analysis of PBMC may be helpful for the treatment of nivolumab.


Subject(s)
Antineoplastic Agents, Immunological/therapeutic use , Biomarkers, Tumor/blood , Melanoma/blood , Nivolumab/therapeutic use , Adult , Aged , Aged, 80 and over , Female , Flow Cytometry , Humans , Male , Melanoma/drug therapy , Middle Aged , T-Lymphocytes, Cytotoxic , Th1 Cells , Th2 Cells , Treatment Outcome
10.
Sci Rep ; 8(1): 5522, 2018 04 03.
Article in English | MEDLINE | ID: mdl-29615641

ABSTRACT

The anti-inflammatory effect of omega 3 polyunsaturated fatty acids has been confirmed in various inflammatory disease models. Maresin-1 (MaR1) is a lipid mediator derived from the omega-3 fatty acid docosahexaenoic acid (DHA) that has displayed strong anti-inflammatory effects in various inflammatory disease models. However, the effect of topical MaR1 on cutaneous inflammation remains unclear. Therefore, we initially examined the anti-inflammatory effects of topical Maresin-1 using an imiquimod (IMQ)-induced psoriasis-like mouse model of inflammation. Topical MaR1 reduced the ear swelling response as seen in histological findings. RT-PCR and flow cytometry analyses revealed MaR1 had no inhibitory effect on IL-23, but MaR1 suppressed IL-17A production by γδTCRmid+ and CD4+ cells in the skin. These inhibitory effects were also observed in a subcutaneous IL-23-injected psoriasis model. MaR1 downmodulated IL-23 receptor (IL-23R) expression by suppressing retinoic acid-related orphan receptor γt (RORγt) expression and internalization in a clathrin-dependent manner in γδTCRmid+ and CD4+ cells. These results lead to assumptions that topical MaR1 may be a new therapeutic agent for psoriasis and other IL-17-mediated cutaneous inflammatory diseases.


Subject(s)
Docosahexaenoic Acids/pharmacology , Gene Expression Regulation/drug effects , Imiquimod/pharmacology , Receptors, Interleukin/metabolism , Skin/drug effects , Animals , CD4-Positive T-Lymphocytes/drug effects , CD4-Positive T-Lymphocytes/metabolism , Docosahexaenoic Acids/therapeutic use , Inflammation/chemically induced , Inflammation/drug therapy , Interleukin-17/biosynthesis , Intraepithelial Lymphocytes/drug effects , Intraepithelial Lymphocytes/metabolism , Mice , Skin/immunology , Skin/metabolism
12.
Exp Dermatol ; 23(5): 347-8, 2014 May.
Article in English | MEDLINE | ID: mdl-24684646

ABSTRACT

BRAF-activating somatic mutations often exist in malignant melanoma. The underlying molecular mechanism of somatic BRAF mutation inductions remained to be clear. Activation-induced cytidine deaminase (AID), a member of a cytidine deaminase family, and APOBEC3B induce somatic mutations and recently have been indicated to be involved in the pathomechanism of several kinds of cancers. The aim of this study was to explore the expression level of AID and APOBEC3B in BRAF-mutation- containing malignant melanoma. Immunohistochemical study demonstrated that 9 of 10 malignant melanomas with high AID expression had BRAF(V600E) mutation. Eight of them developed multiorgan metastases or multiple lymph node metastases afterwards. Although the size of the patient panel was small, the results indicate that there might be an association between AID expression and BRAF mutation in melanoma.


Subject(s)
Cytidine Deaminase/metabolism , Melanoma/enzymology , Proto-Oncogene Proteins B-raf/genetics , Skin Neoplasms/enzymology , Aged , Aged, 80 and over , Cytidine Deaminase/genetics , Female , Gene Expression Regulation, Neoplastic , Humans , Immunohistochemistry , Lymphatic Metastasis , Male , Melanoma/genetics , Middle Aged , Mutation , Skin Neoplasms/genetics
13.
J Invest Dermatol ; 134(7): 1912-1921, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24569709

ABSTRACT

Psoriasis is a common chronic inflammatory skin disease that involves dysregulated interplay between immune cells and keratinocytes. Recently, it has been reported that IL-23 induces CCR6+ γδ T cells, which have the pivotal role in psoriasis-like skin inflammation in mice of producing IL-17A and IL-22. Langerhans cells (LCs) are a subset of dendritic cells that reside in the epidermis and regulate immune responses. The role of LCs has been extensively investigated in contact hypersensitivity, but their role in psoriasis remains to be clarified. In this study, we focused on Th17-related factors and assessed the role of LCs and γδ T cells in the development of psoriasis using a mouse psoriasis model triggered by topical application of imiquimod (IMQ). LC depletion by means of diphtheria toxin (DT) in Langerin DT receptor-knocked-in mice suppressed hyperkeratosis, parakeratosis, and ear swelling in the IMQ-treated regions. In addition, LC-depleted mice showed decreased levels of Th17-related cytokines in IMQ-treated skin lesions. Moreover, the IMQ-treated skin of LC-depleted mice showed a decreased number of IL-17A-producing CCR6+ γδ T cells. These results suggest that LCs are required for the development of psoriasis-like lesions induced by IMQ in mice.


Subject(s)
Interleukin-17/immunology , Interleukin-23 Subunit p19/immunology , Langerhans Cells/immunology , Psoriasis/immunology , Receptors, Antigen, T-Cell, gamma-delta/immunology , Adjuvants, Immunologic/pharmacology , Aminoquinolines/pharmacology , Animals , Dermatitis, Contact/immunology , Disease Models, Animal , Imiquimod , Interleukin-12/immunology , Interleukin-12/metabolism , Interleukin-17/genetics , Interleukin-17/metabolism , Interleukin-23 Subunit p19/genetics , Interleukin-23 Subunit p19/metabolism , Interleukins/genetics , Interleukins/immunology , Interleukins/metabolism , Langerhans Cells/cytology , Langerhans Cells/metabolism , Lymph Nodes/cytology , Lymph Nodes/immunology , Mice , Mice, Inbred C57BL , Organ Culture Techniques , Psoriasis/chemically induced , RNA, Messenger/metabolism , Receptors, Antigen, T-Cell, gamma-delta/metabolism , Receptors, CCR6/immunology , Receptors, CCR6/metabolism , Skin/cytology , Skin/immunology , Transplantation Chimera/immunology , Interleukin-22
14.
Sci Rep ; 3: 2973, 2013 Oct 17.
Article in English | MEDLINE | ID: mdl-24131900

ABSTRACT

Pellagra is a photosensitivity syndrome characterized by three "D's": diarrhea, dermatitis, and dementia as a result of niacin deficiency. However, the molecular mechanisms of photosensitivity dermatitis, the hallmark abnormality of this syndrome, remain unclear. We prepared niacin deficient mice in order to develop a murine model of pellagra. Niacin deficiency induced photosensitivity and severe diarrhea with weight loss. In addition, niacin deficient mice exhibited elevated expressions of COX-2 and PGE syntheses (Ptges) mRNA. Consistently, photosensitivity was alleviated by a COX inhibitor, deficiency of Ptges, or blockade of EP4 receptor signaling. Moreover, enhanced PGE2 production in niacin deficiency was mediated via ROS production in keratinocytes. In line with the above murine findings, human skin lesions of pellagra patients confirmed the enhanced expression of Ptges. Niacin deficiency-induced photosensitivity was mediated through EP4 signaling in response to increased PGE2 production via induction of ROS formation.


Subject(s)
Dinoprostone/metabolism , Niacin/deficiency , Photosensitivity Disorders/metabolism , Reactive Oxygen Species/metabolism , 6-Aminonicotinamide/pharmacology , Animals , Cyclooxygenase 2/genetics , Cyclooxygenase 2/metabolism , Cyclooxygenase 2 Inhibitors/pharmacology , Dermatitis/etiology , Dermatitis/metabolism , Dermatitis/pathology , Disease Models, Animal , Female , Gene Expression , Humans , Mice , Niacin/antagonists & inhibitors , Photosensitivity Disorders/etiology , Photosensitivity Disorders/pathology , Signal Transduction/drug effects , Ultraviolet Rays/adverse effects
15.
Leuk Lymphoma ; 54(3): 520-7, 2013 Mar.
Article in English | MEDLINE | ID: mdl-22830614

ABSTRACT

Approximately 50% of patients with adult T-cell leukemia/lymphoma (ATLL) have skin involvement, and the smoldering, skin lesion-bearing cases are often treated with various skin-directed therapies, such as phototherapy and radiation therapy. Daily oral administration of etoposide plus prednisolone (EP) is also used for smoldering-type ATLL. However, it remains unclear whether these therapies improve patients' survival. We retrospectively analyzed the prognosis of patients with smoldering, skin lesion-bearing ATLL (n = 62), who were treated, as first therapy, with one skin-directed therapy (n = 29), oral EP alone (n = 14) or a combination of skin-directed therapy and oral EP (n = 19). Multivariate analysis revealed that the hazard ratios (HRs) for the overall survival (OS) and progression-free survival (PFS) with the combination therapy were significantly lower than those with the skin-directed therapy (HR 0.1, p = 0.001; HR 0.2, p = 0.002, respectively). These results suggest that the combination of skin-directed therapy and oral EP improves the clinical outcome of patients with smoldering, skin lesion-bearing ATLL.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Leukemia-Lymphoma, Adult T-Cell/therapy , Skin/radiation effects , Ultraviolet Therapy/methods , Administration, Oral , Adult , Aged , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Combined Modality Therapy , Drug Administration Schedule , Etoposide/administration & dosage , Etoposide/adverse effects , Fatigue/etiology , Female , Humans , Kaplan-Meier Estimate , Leukemia-Lymphoma, Adult T-Cell/pathology , Leukopenia/etiology , Male , Middle Aged , Multivariate Analysis , Outcome Assessment, Health Care/statistics & numerical data , Prednisolone/administration & dosage , Prednisolone/adverse effects , Proportional Hazards Models , Retrospective Studies , Skin/pathology , Ultraviolet Therapy/adverse effects , Vomiting/etiology
16.
J UOEH ; 34(1): 85-9, 2012 Mar 01.
Article in Japanese | MEDLINE | ID: mdl-22428462

ABSTRACT

There are increasing cases of wheat dependent exercise-induced anaphylaxis (WDEIA) with transcutaneous or transmucosal sensitization. Hydrolyzed wheat included in a certain brand of soap was identified as a cause of sensitization. The useful clues to detect this disorder consist of the patient's past usage of a soap containing hydrolyzed wheat, the appearance of cutaneous or mucosal symptoms after the intake of wheat or washing with this soap, and a high level of specific IgE for wheat gluten. Because hydrolyzed wheat is used as an additive in a wide variety of cosmetics, we should pay careful attention to the ingredients of cosmetics when observing WDEIA.


Subject(s)
Allergens/immunology , Anaphylaxis/immunology , Exercise , Plant Proteins/immunology , Soaps/adverse effects , Triticum/immunology , Wheat Hypersensitivity/immunology , Adult , Female , Humans , Hydrolysis
SELECTION OF CITATIONS
SEARCH DETAIL
...